Line 2: |
Line 2: |
| | | |
| ==Myeloproliferative Neoplasms (MPN)== | | ==Myeloproliferative Neoplasms (MPN)== |
| + | |
| *[[HAEM5:Chronic myeloid leukaemia]] | | *[[HAEM5:Chronic myeloid leukaemia]] |
| *[[HAEM5:Chronic neutrophilic leukaemia]] | | *[[HAEM5:Chronic neutrophilic leukaemia]] |
Line 18: |
Line 19: |
| '''Cancer Category/Type''' | | '''Cancer Category/Type''' |
| | | |
− | Put your text here | + | Put your text here |
| | | |
| | | |
Line 154: |
Line 155: |
| <br /> | | <br /> |
| {| class="wikitable" | | {| class="wikitable" |
− | |'''Chr #''' | + | |'''Chr #''' |
| |'''Gain/Loss/Amp/LOH''' | | |'''Gain/Loss/Amp/LOH''' |
| |'''Minimal Region Genomic Coordinates [Genome Build]''' | | |'''Minimal Region Genomic Coordinates [Genome Build]''' |
Line 161: |
Line 162: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |
Line 238: |
Line 239: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |
Line 286: |
Line 287: |
| |'''Prognostic Significance''' | | |'''Prognostic Significance''' |
| | | |
− | '''(Yes, No or Unknown)''' | + | '''(Yes, No or Unknown)''' |
| |'''Therapeutic Significance''' | | |'''Therapeutic Significance''' |
| | | |